Close Menu

NEW YORK (GenomeWeb) – Following a nearly 4 percent drop in February, the GenomeWeb continued its downward trend, falling 2 percent for the month of March.

The decline matched the struggles of the broader stock market. The Dow Jones Industrial Average was down almost 4 percent month over month, while the Nasdaq Composite was down about 3 percent. The Nasdaq Biotech dropped 1 percent from the end of February.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.